Jubilant Life Sciences gets US FDA’s nod for Indomethacin ER Capsule

07 Oct 2015 Evaluate

Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Indomethacin ER Capsule 75mg, which is a non?steriodal anti-inflammatory drug used for treatment of pain.

As on June 30, 2015, the company had a total of 815 filings for formulations of which 389 have been approved in various regions globally. This includes 72 ANDAs filed in the US, of which 38 have been approved and 46 Dossier filings in Europe.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Specialty Pharmaceuticals and Life Science Ingredients.

 

Jubilant Pharmova Share Price

1080.80 10.60 (0.99%)
06-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1760.15
Dr. Reddys Lab 1255.95
Cipla 1530.35
Zydus Lifesciences 931.25
Lupin 2151.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×